Wolverine Asset Management’s Surgery Partners SGRY Stock Holding History

Wolverine Asset Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$912K	Hold	76,529	–	–	0.01%	804
2025 Q4	$1.18M	Buy	76,529 +10,000	+15%	+$184K	0.02%	746
2025 Q3	$1.44M	Hold	66,529	–	–	0.02%	649
2025 Q2	$1.48M	Hold	66,529	–	–	0.02%	602
2025 Q1	$1.58M	Buy	66,529 +43,336	+187%	+$1.03M	0.03%	579
2024 Q4	$491K	Hold	23,193	–	–	0.01%	870
2024 Q3	$748K	Hold	23,193	–	–	0.01%	773
2024 Q2	$552K	Buy	+23,193	New	+$595K	0.01%	819
2024 Q1	–	Sell	-7,713	Closed	-$247K	–	1982
2023 Q4	$247K	Sell	7,713 -9,555	-55%	-$277K	﹤0.01%	1019
2023 Q3	$505K	Sell	17,268 -2,357	-12%	-$84.7K	0.01%	876
2023 Q2	$883K	Sell	19,625 -15,859	-45%	-$605K	0.02%	714
2023 Q1	$1.22M	Sell	35,484 -1,050	-3%	-$34.1K	0.02%	633
2022 Q4	$1.02M	Buy	36,534 +3,293	+10%	+$87.2K	0.02%	742
2022 Q3	$777K	Buy	33,241 +16,700	+101%	+$533K	0.01%	867
2022 Q2	$478K	Buy	16,541 +400	+2%	+$17.5K	0.01%	1001
2022 Q1	$888K	Hold	16,141	–	–	0.01%	792
2021 Q4	$862K	Hold	16,141	–	–	0.01%	845
2021 Q3	$683K	Buy	16,141 +13,742	+573%	+$701K	0.01%	878
2021 Q2	$159K	Buy	+2,399	New	+$130K	﹤0.01%	1334
2021 Q1	–	Sell	-18,754	Closed	-$544K	–	2331
2020 Q4	$544K	Sell	18,754 -22,936	-55%	-$571K	0.01%	822
2020 Q3	$913K	Sell	41,690 -80,000	-66%	-$1.42M	0.01%	590
2020 Q2	$1.41M	Buy	121,690 +4,304	+4%	+$47.2K	0.02%	461
2020 Q1	$766K	Buy	117,386 +48,185	+70%	+$687K	0.02%	575
2019 Q4	$1.08M	Sell	69,201 -166,578	-71%	-$1.89M	0.02%	601
2019 Q3	$1.74M	Buy	235,779 +72,406	+44%	+$518K	0.04%	459
2019 Q2	$1.33M	Buy	163,373 +58,977	+56%	+$588K	0.03%	550
2019 Q1	$1.18M	Sell	104,396 -26,410	-20%	-$333K	0.03%	602
2018 Q4	$1.28M	Buy	130,806 +67,750	+107%	+$909K	0.03%	703
2018 Q3	$1.04M	Sell	63,056 -7,107	-10%	-$113K	0.02%	786
2018 Q2	$1.04M	Buy	70,163 +58,336	+493%	+$978K	0.03%	754
2018 Q1	$202K	Sell	11,827 -160,917	-93%	-$2.51M	﹤0.01%	1151
2017 Q4	$2.09M	Sell	172,744 -1,026	-0.6%	-$9.81K	0.04%	504
2017 Q3	$1.8M	Buy	+173,770	New	+$2.48M	0.05%	513